Drupal.behaviors.print = function(context) {window.print();window.close();}>
Alnylam Pharmaceuticals, Kyowa Hakko, Intradigm, SiRNAsense, Polyplus-Transfection, Invitrogen, Applied Biosystems, Millipore, Scripps Research Institute
June 19, 2008
Alnylam Pharmaceuticals, Kyowa Hakko, Intradigm, SiRNAsense, Polyplus-Transfection, Invitrogen, Applied Biosystems, Millipore, Scripps Research Institute
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
UniQure, Collaborators Secure $3.2M Eurostar Grant for Huntington’s Disease Effort
May 23, 2013 / Gene Silencing News
NIH Awards $400K to Fund Three microRNA Research Grants in May
May 23, 2013 / Gene Silencing News
Alnylam Releases Proof-of-concept Data on Preclinical Porphyria Drug
May 23, 2013 / Gene Silencing News
MiRagen Hits First Milestone in Servier microRNA Drug Partnership
May 23, 2013 / Gene Silencing News
Cenix to Provide Research Services to Debiopharm
May 23, 2013 / Gene Silencing News